Armando Torres Nieves, MD
Infectious Disease · San Juan, PRNPI 1346270790
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,733 of the $4,233 with a category attached, or 64.6%. 17 manufacturers reported payments, led by C. R. Bard, Inc. & Subsidiaries at 35.4% of the total. Reporting peaked in 2019 at $2,116 and has fallen 81.7% since, to $388 in 2025.
Across 43 payments — averaging $98.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- C. R. Bard, Inc. & Subsidiaries$2K
- AstraZeneca$818
- EMD Serono, Inc.$373
- Biogen$206
- Shionogi Inc$151
- E.r. Squibb & Sons, L.L.C.$142
- plus $1K from 11 others
What the payments were for
- Food & beverage$2,73365%
- Gifts$1,50035%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| C. R. Bard, Inc. & Subsidiaries | 1 | $1,500 |
| AstraZeneca | 7 | $818 |
| EMD Serono, Inc. | 3 | $373 |
| Biogen | 2 | $206 |
| Shionogi Inc | 2 | $151 |
| E.r. Squibb & Sons, L.L.C. | 3 | $142 |
| Viiv Healthcare Company | 1 | $125 |
| UCB, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $124 |
| Johnson & Johnson | 2 | $123 |
| Argenx US, Inc. | 1 | $118 |
| Amgen | 1 | $110 |
| Sanofi | 1 | $90 |
| AbbVie | 1 | $84 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $80 |
| Gilead | 2 | $46 |
| PBG Puerto Rico LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,233 in reported general payments places this provider in the 85th percentile of 127 infectious disease providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in San Juan
- Vanessa Olivo EchavarrySan Juan$41K
- Angeles Rodriguez RosaSan Juan$27K
- Miguel Colon PerezSan Juan$12K
- Javier MoralesSan Juan$9K
- Mario LopezSan Juan$9K
- Carmelo Santana-LopezSan Juan$4K
- Elba Arroyo CamunasSan Juan$3K
- Jonathan Ruiz GarciaSan Juan$3K
- Sandra Maldonado-RiveraSan Juan$3K
- Jaime CatalaSan Juan$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.